Breakdown | TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 265.57M | 262.08M | 251.43M | 223.93M | 165.09M | 195.79M |
Gross Profit | 32.97M | 31.70M | 31.45M | 29.92M | 20.92M | 23.33M |
EBITDA | 3.65M | 3.86M | 6.92M | 7.54M | 4.55M | 3.16M |
Net Income | -1.08M | -1.20M | 2.52M | 3.00M | 1.41M | -252.00K |
Balance Sheet | ||||||
Total Assets | 103.03M | 99.54M | 100.03M | 84.49M | 94.82M | 96.28M |
Cash, Cash Equivalents and Short-Term Investments | 2.08M | 438.00K | 4.23M | 2.76M | 5.74M | 1.48M |
Total Debt | 16.70M | 35.80M | 33.58M | 27.23M | 39.25M | 45.11M |
Total Liabilities | 72.98M | 70.81M | 68.37M | 49.76M | 67.23M | 69.89M |
Stockholders Equity | 30.04M | 28.74M | 31.66M | 34.73M | 27.59M | 26.38M |
Cash Flow | ||||||
Free Cash Flow | -1.46M | -2.46M | 3.33M | 553.00K | 6.33M | -1.78M |
Operating Cash Flow | -159.00K | 119.00K | 4.24M | 3.39M | 6.72M | -802.00K |
Investing Cash Flow | -1.06M | -2.33M | -716.00K | -2.65M | -209.00K | -795.00K |
Financing Cash Flow | 560.00K | -1.57M | -2.05M | -3.71M | -2.26M | -833.00K |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
77 Outperform | £282.85M | 7.19 | 13.74% | 621.31% | 6.77% | 32.64% | |
76 Outperform | £2.84B | 7.41 | 18.69% | 336.19% | -19.08% | 57.32% | |
74 Outperform | £197.64M | 11.42 | 5.09% | 367.41% | 0.94% | -28.04% | |
64 Neutral | £1.70B | 12.12 | 6.12% | 261.24% | 0.58% | -32.48% | |
39 Underperform | £12.95M | 73.64 | 0.60% | 210.53% | -0.42% | -183.34% |